CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,799 | +356.0% | 282 | +464.0% | 0.00% | – |
| Q2 2023 | $2,807 | +24.1% | 50 | 0.0% | 0.00% | – |
| Q1 2023 | $2,261 | +11.3% | 50 | 0.0% | 0.00% | – |
| Q4 2022 | $2,032 | -32.3% | 50 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -94.1% | 50 | -92.7% | 0.00% | – |
| Q4 2021 | $51,000 | -81.7% | 684 | -72.5% | 0.00% | -100.0% |
| Q3 2021 | $278,000 | +3375.0% | 2,484 | +4868.0% | 0.00% | – |
| Q2 2021 | $8,000 | +33.3% | 50 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | -88.7% | 50 | -85.7% | 0.00% | – |
| Q4 2020 | $53,000 | +112.0% | 350 | +16.7% | 0.00% | – |
| Q3 2020 | $25,000 | +13.6% | 300 | 0.0% | 0.00% | – |
| Q2 2020 | $22,000 | +83.3% | 300 | 0.0% | 0.00% | – |
| Q1 2020 | $12,000 | -33.3% | 300 | 0.0% | 0.00% | – |
| Q4 2019 | $18,000 | +50.0% | 300 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | -14.3% | 300 | 0.0% | 0.00% | – |
| Q2 2019 | $14,000 | +40.0% | 300 | 0.0% | 0.00% | – |
| Q1 2019 | $10,000 | +25.0% | 300 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -38.5% | 300 | 0.0% | 0.00% | – |
| Q3 2018 | $13,000 | -23.5% | 300 | 0.0% | 0.00% | – |
| Q2 2018 | $17,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |